Intravenous infusion of total dose iron is superior to oral iron in treatment of anemia in peritoneal dialysis patients: A single center comparative study

Journal of the American Society of Nephrology

Volumn 9, Issue 4, 1998, Pages 664-668

  Ahsan, Nasimul ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; FERROUS SULFATE; IRON BINDING PROTEIN; IRON DEXTRAN; TRANSFERRIN;

ADULT; ANEMIA; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CLINICAL TRIAL; DIALYSIS; DRUG SAFETY; FEMALE; HEMATOCRIT; HEMATOLOGICAL PARAMETERS; HUMAN; IRON DEFICIENCY ANEMIA; KIDNEY FAILURE; MALE; ORAL DRUG ADMINISTRATION; PERITONEAL DIALYSIS; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

EID: 0031897948     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Esbach JW, Egrie JC, Downing MR: Correction of anemia of end-stage renal disease with recombinant human erythropoietin: Results of a combined phase I and II clinical trial. N Engl J Med 316: 73-78, 1987
2. Levin NMN, Lazarus JM, Nissenson AR: National cooperative rHu erythropoietin study in patients with chronic renal failure: An interim report. Am J Kidney Dis 22: 3-12, 1993
3. Van Wyck DB, Stivelman JC, Ruiz J: Iron status in patients receiving erythropoietin for dialysis-associated anemia. Kidney Int 35: 712-716, 1989
4. Fishbane S, Maesaka JK: Iron management in end-stage renal disease. Am J Kidney Dis 29: 319-333, 1997
5. Macdougall IC: Poor response to erythropoietin: Practical guidelines on investigation and management. Nephrol Dial Transplant 10: 607-614, 1995
6. Macdougall IC, Hutton RD, Cavill I, Coles GA, Williams JD: Poor response to treatment of renal anemia with erythropoietin corrected by iron given intravenously. Br Med J 299: 157-158, 1989
7. Sunder-Plassmann G, Hörl WH: Importance of iron supply for erythropoietin therapy. Nephrol Dial Transplant 10: 2070-2079, 1995
8. Schaefer RM, Schaefer L: Management of iron substitution during r-HuEPO therapy in chronic renal failure patients. Erythropoiesis 3: 71-75, 1992
9. Macdougall IC: Monitoring of iron status and iron supplementation in patients treated with erythropoietin. Curr Opin Nephrol Hypertens 3: 620-625, 1994
10. Fishbane S, Lynn RI: The efficacy of iron dextran for the treatment of iron deficiency in hemodialysis patients. Clin Nephrol 44: 238-240, 1995
11. Bonnar J, Goldberg A, Smith JA: Do pregnant women take their iron? Lancet 1: 457-458, 1969
12. Forth W, Rummel W: Iron absorption. Physiol Rev 53: 724-792, 1973
13. Brise H, Hallberg L: Iron absorption studies. Acta Med Scand 171: 1-9, 1962
14. Fishbane S, Frei GL, Maesaka J: Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation. Am J Kidney Dis 26: 41-46, 1995
15. Taylor JE, Peat N, Porter C, Morgan AG: Regular, low-dose intravenous iron therapy improves response to erythropoietin in hemodialysis patients. Nephrol Dial Transplant 11: 1079-1083, 1996
16. Macdougall IC, Tucker B, Thompson J, Tomson CRV, Baker LRI, Raine AEG: A randomized controlled study of iron supplementation in patient treated with erythropoietin. Kidney Int 50: 1694-1699, 1996
17. Suh H, Wadhwa NK: Iron dextran treatment in peritoneal dialysis patients on erythropoietin. Adv Peril Dial 8: 464-466, 1992
18. Ahsan N, Groff JA, Waybill MM: Efficacy of bolus intravenous iron dextran treatment in peritoneal dialysis patients receiving recombinant human erythropoietin. Adv Perit Dial 12: 161-166, 1996
19. Rao DS, Shih MS, Mohini R: Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia. N Engl J Med 328: 171-175, 1993
20. Bia MJ, Cooper K, Schnall S: Aluminum induced anemia: Pathogenesis and treatment in patients on chronic hemodialysis. Kidney Int 36: 852-858, 1989
21. Ifudu O, Feldman EA: The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease. N Engl J Med 334: 420-425, 1996
22. McGonigle RJ, Wallin JD, Shadduck RK, Fisher JW: Erythropoietin deficiency and inhibition of erythropoiesis in renal insufficiency. Kidney Int 25: 437-444, 1984
23. Tarng DC, Chen TW, Huang TP: Iron metabolism indices for early prediction of the response and resistance to erythropoietin therapy in maintenance hemodialysis patients. Am J Nephrol 15: 230-237, 1995
24. U.S. Renal Data Systems: The USRDS dialysis morbidity and mortality study (Wave 1). In: U.S. Renal Data Systems 7996: Annual Data Report, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 1996, pp 45-46
25. Council on Food and Nutrition, for the Committee on Iron Deficiency: Iron deficiency in the United States. JAMA 203: 119-124, 1968
26. Silverberg DS, Iaina A, Peer G, Kaplan E, Levi B, Frank N, Steinbruch S, Blum M: Intravenous iron supplementation for the treatment of the anemia of moderate to severe chronic renal failure patients not receiving dialysis. Am J Kidney Dis 27: 234-238, 1996
27. Wingard RL, Parker RA, Ismail N: Efficacy of oral iron therapy in patients receiving recombinant human erythropoietin. Am J Kidney Dis 25: 433-439, 1995
28. Magna L, Shar SK, Smith EC, Martinez C: Iron absorption and utilization in maintenance hemodialysis patients: Oral and intravenous routes. Mt Sinai J Med 54: 180-183, 1984
29. Koistra MP, van Es A, Struyvenberg A, Marx JJM: Low iron absorption in erythropoietin-treated hemodialysis patients [Abstract]. J Am Soc Nephrol 6: 543, 1995
30. Kanakakorn K, Cavil I, Jacobs A: The metabolism of intravenously administered iron dextran. Br J Haematol 25: 637-643, 1973
31. Donnelly SM, Posen GA, Ali MAM: Oral iron absorption in hemodialysis patients treated with erythropoietin. Clin Invest Med 14: 272-276, 1991
32. Michelson E: Anaphylactoid reaction to dextran. N Engl J Med 278: 552, 1968
33. Fishbane S, Ungureanu VD, Maesaka JK, Ada G, Kaupke CJ, Lim V, Wish J: A multicenter study of the safety of intravenous iron dextran in hemodialysis patients. Am J Kidney Dis 28: 529-534, 1996
34. Hamastra RD, Block MH, Schocket AL: Intravenous iron dextran in clinical medicine. JAMA 243: 1726-1731, 1980
35. Carthew P, Edwards RE, Smith AG: Rapid induction in hepatic fibrosis in the gerbil after the parenteral administration of iron-dextran complex. Hepatology 13: 34-39, 1991